Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
April 25, 2019
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Naveen Pemmaraju, Andrew A Lane, Kendra L Sweet, et al.
Leukemia & Lymphoma
|
September 4, 2023
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia
Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
The Journal of Clinical Investigation
|
October 25, 2016
MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L Mundy-Bosse, Steven D Scoville, Li Chen, et al.
American Journal of Hematology
|
August 11, 2020
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Caner Saygin, Karilyn Larkin, James S Blachly, et al.
Blood
|
December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia
Shujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
William Blum, Rebecca B Klisovic, Heiko Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Blood
|
December 8, 2009
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway
Rosa Lapalombella, Leslie Andritsos, Qing Liu, et al.
Blood
|
March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts
Sumithira Vasu, Shun He, Carolyn Cheney, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
April 25, 2019
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Naveen Pemmaraju, Andrew A Lane, Kendra L Sweet, et al.
Leukemia & Lymphoma
|
September 4, 2023
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia
Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
The Journal of Clinical Investigation
|
October 25, 2016
MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L Mundy-Bosse, Steven D Scoville, Li Chen, et al.
American Journal of Hematology
|
August 11, 2020
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Caner Saygin, Karilyn Larkin, James S Blachly, et al.
Blood
|
December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia
Shujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
William Blum, Rebecca B Klisovic, Heiko Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Blood
|
December 8, 2009
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway
Rosa Lapalombella, Leslie Andritsos, Qing Liu, et al.
Blood
|
March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts
Sumithira Vasu, Shun He, Carolyn Cheney, et al.
Page
of 12